PATH Virtual Conference

WE02 - Session 2: Autism Spectrum Disorder

May 17, 2017 10:20am ‐ May 17, 2017 11:23am


The purpose of this presentation is to provide participants with information autism spectrum disorder (ASD). Diagnostic criteria for ASD will be reviewed, as well as the differences between typical and atypical development. We will discuss the signs that suggest a child should undergo assessment to rule out the presence of ASD. Prevalence and etiologic factors associated with ASD will be presented, as well as associated medical conditions, comorbidities, and work-up. Information about diagnostic assessments and some types of interventions will be provided. While the focus will be on children, some of the challenges faced by youth and adults with ASD also will be presented.

Sandra Friedman, MD, MPH is the William K. Frankenburg Research Professor in Developmental Behavioral Pediatrics, and Section Head of Developmental Pediatrics at the University of Colorado School of Medicine (UCSOM) and Children’s Hospital Colorado. She also is Director of JFK Partners, directing the University Center for Excellence in Developmental Disabilities and Leadership Education in Neurodevelopmental Disabilities Programs. She serves as Program Director for the Developmental Behavioral Pediatric (DBP) Fellowship program at UCSOM, and previously was program Director for Neurodevelopmental Disabilities (NDD) Residency Program at Boston Children’s Hospital. She is site PI for the DBPNet, a research network of 14 DBP programs. She is board certified in Pediatrics, Neurodevelopmental Disabilities, and Developmental Behavioral Pediatrics. Dr. Friedman has served on multiple disability-related boards of directors, advisory and executive committees, and has been involved in policy, practice, and administrative issues that affect the lives of people with disabilities and the field.


You must be logged in and own this session in order to post comments.